Arhalofenate
Arhalofenate (JNJ 39659100) is a selective partial PPARγ agonist developed for type 2 diabetes research. It has been investigated in both in vitro assays and in vivo models for its potential to improve glycemic control and insulin sensitization.
Product Specifications
CAS Number
24136-23-0
Product Name Alternative
Arhalofenate, inhibit, JNJ39659100, JNJ-39659100, JNJ 39659100, Inhibitor, MBX 102, MBX102, MBX-102, PPAR-γ, PPARγ, PPAR, Peroxisome proliferator-activated receptors
Field of Research
Metabolism Research, Molecular Biology
Purity
98.97% (May vary between batches)
Solubility
DMSO:132.5 mg/mL (318.67 mM)
Smiles
[C@H] (OC1=CC (C (F) (F) F) =CC=C1) (C (OCCNC (C) =O) =O) C2=CC=C (Cl) C=C2
Molecular Formula
C19H17ClF3NO4
Molecular Weight
415.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15313348 1 Vial
Lentiviral human HSD11B2 shRNA (UAS) - Lentiviral human HSD11B2 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
GTR15332181 1 Vial
Lentiviral human STARD8 shRNA (UAS) - Lentiviral human STARD8 shRNA (UAS) (100)
Sign In for Pricing
View Details